priority reviewIf PLI get the « priority review status» by the FDA we can say that before they start this review , for PLI this is will be a «news release » in itself with a good effect on the share price knowing the delay is shortened .
Some criteria for the priority reviews must be in line with the fast track designation,who is in line with the study data ,what can go wrong ???? By april 5 , the shorters can have more difficulty recruiting people in there gang , so i think the share price will climb slowly but steady.
Am i ok or outside the track???????????